Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/33
Title: | Inapparent outbreaks of ventilator-associated pneumonia: an ecologic analysis of prevention and cohort studies. |
Authors: | Hurley, James C. |
Issue Date: | 2005 |
Publisher: | University of Chicago Press |
Place of publication: | Chicago |
Publication Title: | Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America |
Volume: | 26 |
Issue: | 4 |
Start Page: | 374 |
End Page: | 390 |
Abstract: | OBJECTIVE: To compare ventilator-associated pneumonia (VAP) rates and patterns of isolates across studies of antibiotic and non-antibiotic methods for preventing VAP. DESIGN: With the use of 42 cohort study groups as the reference standard, the prevalence of VAP was modeled in two linear regressions: one with the control groups and the other with the intervention groups of 96 VAP prevention studies. The proportion of patients admitted with trauma and the VAP diagnostic criteria were used as ecologic correlates. Also, the patterns of pathogenic isolates were available for 117 groups. RESULTS: In the first regression model, the VAP rates for the control groups of antibiotic-based prevention studies were at least 18 (CI95, 12 to 24) per 100 patients higher than those in the cohort study groups (P < .001). By contrast, comparisons of cohort study groups with all other control and intervention groups in the first and second regression models yielded differences that were less than 6 per 100 and not significant (P > .05). For control groups with VAP rates greater than 35%, the patterns of VAP isolates, such as the proportion of Staphylococcus aureus, more closely resembled those in the corresponding intervention groups than in the cohort groups. CONCLUSIONS: The rates of VAP in the control groups of the antibiotic prevention studies were significantly higher than expected and the patterns of pathogenic isolates were unusual. These observations suggest that inapparent outbreaks of VAP occurred in these studies. The possibility remains that antibiotic-based VAP prevention presents a major cross-infection hazard. |
URI: | http://hdl.handle.net/11054/33 |
Resource Link: | http://www.jstor.org/stable/10.1086/502555 |
ISSN: | 0899-823X |
Internal ID Number: | 00020 |
Health Subject: | ANTI-BACTERIAL AGENTS - THERAPEUTIC USE CASE CONTROL STUDIES DISEASE OUTBREAKS - PREVENTION AND CONTROL ENVIRONMENTAL MONITORING PNEUMONIA - EPIDEMIOLOGY PNEUMONIA - ETIOLOGY PNEUMONIA - PREVENTION AND CONTROL PSEUDOMONAS AERUGINOSA - ISOLATION AND PURIFICATION PSEUDOMONAS AERUGINOSA - PATHOGENICITY RESPIRATION - ARTIFICIAL - ADVERSE EFFECTS STAPHYLOCOCCUS AUREUS - ISOLATION AND PURIFICATION STAPHYLOCOCCUS AUREUS - PATHOGENICITY ANTI-BACTERIAL AGENTS |
Type: | Journal Article Article |
Appears in Collections: | Research Output |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.